Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration.

PLoS pathogens·2026

Same author

The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration.

bioRxiv : the preprint server for biology·2025

Same author

Improved survival of SARS COV-2-infected K18-<i>hACE2</i> mice treated with adenosine A<sub>2A</sub>R agonist.

Heliyon·2023

Same author

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.

PloS one·2023

Same author

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.

Science immunology·2023

Same author

Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection.

Frontiers in immunology·2022

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

Rationally designed tularemia vaccines.

Barbara J Mann¹, Nicole M Ark

¹Departments of Medicine & Microbiology, University of Virginia Health Systems, Charlottesville, VA 22908, USA. bjm2r@virginia.edu

Expert Review of Vaccines

|June 23, 2009

Summary

Tularemia, a severe bacterial disease, is being researched for new vaccines. Advances in genetic manipulation and vaccine development offer hope for effective prevention strategies against Francisella tularensis.

Area of Science:

Microbiology
Immunology
Vaccinology

Background:

Tularemia is a severe, potentially fatal disease caused by Francisella tularensis.
Transmission occurs via arthropod vectors or inhalation, posing public health concerns.
Renewed research interest stems from its potential as a biological weapon.

Purpose of the Study:

To review progress in vaccine development for tularemia.
To highlight the impact of genetic manipulation techniques on F. tularensis research.
To discuss different vaccine platforms for tularemia prevention.

Main Methods:

Review of current literature on F. tularensis research and vaccine development.
Analysis of advances in genetic manipulation of Francisella tularensis.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Related Experiment Videos

Last Updated: Jun 22, 2026

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis

Published on: September 30, 2017

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Examination of established vaccine development strategies for bacterial pathogens.

Main Results:

Significant progress has been made in understanding F. tularensis.
Genetic manipulation tools are accelerating vaccine candidate development.
Multiple vaccine approaches, including live-attenuated and subunit vaccines, are being explored.

Conclusions:

Tularemia vaccine development is advancing rapidly.
New strategies leverage genetic engineering and established vaccine platforms.
Effective vaccines are crucial for addressing tularemia risks.